January 3, 2023 Lab Top-10 PAI Top-10

Thermo Fisher Scientific Completes Acquisition of The Binding Site Group

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma  Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing Diagnostics Segment WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today... Read more

December 6, 2022 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10

Thermo Fisher Scientific Raises Greenhouse Gas Emissions Reduction Target on Path to Net-zero Emissions

Company to achieve 2030 Scope 1 and 2 greenhouse gas emissions reduction target of 30% ahead of schedule; increases ambition to 50% reduction, aligned with 1.5˚C pathway WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a new 2030 greenhouse gas emissions reduction target to reduce its... Read more

November 10, 2022 PAI Top-10 PR/Corporate

Notice Concerning Revisions to the Financial Results Forecasts and Dividend Forecasts (Dividend Increase)

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

November 10, 2022 Microscopy PAI Top-10 PR/Corporate

Consolidated Financial Results for the Six Months Ended September 30, 2022 (Under Japanese GAAP)

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

October 31, 2022 Lab Top-10 PAI Top-10

Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy

Announces $1.0 Billion Share Repurchase Program for Q4 2022 Separately Enters Into Agreement to Acquire The Binding Site Group WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment. Throughout the fourth quarter of 2022, Thermo Fisher expects to execute a... Read more

October 31, 2022 Lab Top-10 PAI Top-10

Thermo Fisher Scientific to Acquire The Binding Site Group

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing Diagnostics Segment WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today... Read more

October 26, 2022 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Thermo Fisher Scientific Reports Third Quarter 2022 Results

WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended October 1, 2022. Third Quarter 2022 Highlights Third quarter revenue was $10.68 billion. Third quarter GAAP diluted earnings per share (EPS) was $3.79. Third quarter adjusted EPS was $5.08. Delivered... Read more

October 21, 2022 PAI Top-10

GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy

Collaboration places emphasis on personalized medicine; brings together key precision diagnostic and treatment delivery tools aimed at creating shorter, more comfortable and more effective treatments for patients CHICAGO, IL and SUNNYVALE, Calif., – October 21, 2022: GE Healthcare and Accuray Incorporated (NASDAQ: ARAY) announced today that they have signed a global commercial collaboration agreement designed... Read more

October 20, 2022 PAI Top-10

GE Healthcare Tops List with Highest Number of AI-Enabled Device Authorizations, More Than Any Other Medical Technology Company

Of the more than 500 devices included by the U.S. FDA on a recently updated list of AI-enabled device authorizations, 42 are from GE Healthcare, a milestone that highlights the impact of the company’s digital strategy. Chicago – October 20, 2022 – On a recently updated FDA list of artificial intelligence (AI) enabled medical devices,... Read more